Philip Morris
Helicobacter Pylori Infection: Independent Risk Indicator of Gastric Adenocarcinoma
Fields
- Author
- Andersson, B.
- Athlin, L.
- Bendtsen, O.
- Bergstrom, R.
- Engstrand, L.
- Evans, D.J., J.R.
- Hansson, L.E.
- Lindgren, A.
- Nyren, O.
- Tracz, P.
- Athlin, L.
- Area
- TEWES,FRANZ/INBIFO OFFICE
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Site
- I37
- Request
- Stmn/R2-038
- Named Person
- Hansson, L.E.
- Zettersten, U.
- Document File
- 2029138622/2029138940/Task 5 Mb R016 Disposal Suspension
- Named Organization
- Professor Nanna Svartz Foundation
- Swedish Society of Medicine
- Tpre Nilsson Foundation
- Univ Hospital Uppsala Sweden
- Swedish Society of Medicine
- Author (Organization)
- Univ Hospital Umea Sweden
- Univ Hospital Uppsala Sweden
- Vasteras Hospital Vasteras Sweden
- Veterans Administration
- Dept of Surgery
- Gastroenterology
- Medical Center Houston
- Sala Hospital Sweden
- Skelleftea Hospital Sweden
- Univ Hospital Uppsala Sweden
- Litigation
- Stmn/Produced
- Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- gqy69e00
Document Images
C~pl~.
- - -
STORAGE N°..~~.5........
Input N° .. . .........
GAS'fROENTEROLOGY 1993;105:1098-1103
Nelicobacter pylorl Infection: Independent Risk Indicator of
Gastric Adenocarcinoma
LARS-ERIK HANSSON,*II LARS ENGSTRAND,# OLOF NYREN,II DOYLE J. EVANS, Jr.,'
ANDERS UNDGREN,s REINHOLD BERGSTROM * BENGT ANDERSSON,** LEIF ATHLIN,$
OVE BENDTSEN,19 and PIOTR TRACZII°
Departments of 'Surgery,'Clinical Microbiology, and 'Pathology, and the aCancer Epidemiology Unit,
University Hospital, Uppsala, Sweden;
1Veterans Administration Medical Center, Houston, Texas; "Department of Statistics. University of
Uppsala, Uppsala, Sweden; * *Department
of Surgery, Sala Hospital, Sata, Sweden; ODepartment of Surgery, University Hospital, Ume9, Sweden;
"Department of Surgery, Skellefte9
Hospital, Skellefte9, Swedenc and "iDepartment of Surgery, VasterAs Hospital, Vgsterfis, Sweden
eackoround: He!lcobacter pylorl has been implicated
as a possible etiologic factor in gastric cancer. This
case control study was performed to determine the
association between H. pylorl and gastric cancer, tak-
ing Into account the possibility of confounding by other
background factoid Methods: Sera were collected
from 112 incident case patients with gastric cancer
and 103 control patients with nongastroenterological
diseases, who were frequency-matched with respect
to age and sex. Immunoglobulin G antibodies to H. py-
lorl were Identified using the HM-CAP Immunoassay
(Enteric Products Inc., Wesbury, NY) Results: The prev-
alence of H. pylorl seropositivity was significantly
higher (P a 0.002) among case patients than control
patients. The odds ratio (OR) was 2.60 (95% confi-
dence interval, 1.35-5.02). The increased OR asso-
ciated with H. pylort Infection was confined to tumors
with a noncardla location (OR, 3.06) and men (OR,
4.27). OR increased with decreasing age at cancer
diagnosis to reach 9.33 in patients <60 years of age.
Multivarlate logistic regression analysis was used as
control for potential confounding, but the elevated OR
assoclated with H. pylor! infection remained signifl-
cantly increased. Conclusions: The results support the
hypothesis of H. pylor! infection as an Independent risk
indicator of gastric cancer.
T he microorganism Hrlicobackrpylori is considered a
causative agent of chronic antral gastritis.' Be-
cause it is assumed that gastritis is a risk factor for
cancer of the stomach (at least when it becomes atro-
phic), it has been proposed that H. pylori infection may
be involved in gastric carcinogenesis.t High preva-
ierlce rates of H. pylori infection have been notcd in
populations with a high risk of gastric carcinoma.2-4 In
two case control studiess8 and three nested case con-
trol studies within cohorts,T-9 H. pylori infection was
found to be associated with an increased risk of gastric
cancer. However, as the risk of gastric cancer appears
to be partially determined by dietary30 and socioeco-
nomic" factors, and the latter also seems to be of im-
portance for the risk of contracting H. pylori infec-
tion,'Z there is a possibility that the previously
described association between H. pylori infection and
gastric cancer is a result of cohfounding factors.
To further examine the question of a possible associ-
ation between H. pylori infection and gastric cancer
(taking location, and histological type into consider-
ation), we determined the seroprevalence of H. pylori
immunogiobulin (IgG) antibodies among gastric
cancer case patients and hospital control patients. In-
formation on dietary and socioeconomic conditions
was obtained from all subjects to find out whether
confounding by these variables could be responsible
for an association.
Subjects and Methods
Preoperative venous blood sampleswere collected
from 114 consecutive patients below the age of 80 years
with gastric cancer. The patients received this diagnosis be-
tween 1989 and 1991 at eight hospitals in central and north-
ern Sweden. The upper age limit was chosen because we
expected difficulties in getting reliable answers from those
older than 79 years. These cases constituted 60°1fi of all gas-
tric cancer occurring in the study base. According to the
results in a larger case control study on gastric cancer,13 of
which this study was a part, the remaining patients were
excluded because of advanced malignant disease or early
death (20%), patient's refusal (3%), mental or physical ill-
ness (other than gastric cancer) (3%), or because we were
unable to get a blood sample (14%). The control group con-
sisted of 103 control patients admitted to the same hospitals
for nongastrointestinal diseases, namely, inguinal hernia,
Abbreviations used In this paper: Cl. confidence Intervai; OR, odds
ratio.
~fl 1993 by the American Gastroenterological Association
0016-5085/93/$3.00

I
October 1993
fractures, varicose veins, benign thyroid or prostatic disease,
or benign or malignant breast disease. The control patients
were frequency-matched with respect to 10-year age period,
gende ; and hospital of admission. As there was no individ-
ual matching, the number of case and control patients was
not strictly equal. The case patients were interviewed about
their past access (at the time of adolescence and 20 years
ago) to a refrigerator and freezer (only 20 years ago) and
consumption of vegetables, citrus fruits, and salt. The inter-
view also included questions about the consumption of alco-
hol and coffee 20 years ago. Further questions concerned the
occupation of the respondent's and of their father, geograph-
ical place of residence, history of smoking and snuff dip-
ping, past medical history, and intake of analgesics and HZ-
receptor antagonists. The control patients completed a
questionnaire containing the same questions as those posed
to the case patients. Socioeconomic status was determined
on the basis of the occupational classification as devised by
Statistics Sweden" and was based on the occupation of lon-
gest duration. The case and control patients were classified
into one of three socioeconomic categories. The location of
the tumor within the stomach was determined through a
combined evaluation of special reports from the clinicians
to the investigators, case records, and histopathologic re-
ports. The histological specimens of all cancer patients were
independently reviewed by an experienced pathologist (A.
Lindgren), who was unaware of the results of the other
investigation parameters. After confirmation of the diagno-
sis of adenocarcinoma, the tumors were classified as pro-
posed by Lauren's into the intestinal or diffuse histological
type. Two patients were found at this review not to have
adcnocarcinoma and were thus excluded.
Blood was collected by venepuncture and centrifuged.
The serum samples were then stored at -20°C and kept
frozen on dry ice during transport to the laboratory. A mi-
crobiologist (L. Fngstrand), who did not know the case/
control status of the patient, examined the sera for IgG anti-
bodies to H. pylo,i using the 1-1M-CAP immunoassay
(I3nteric Products Inc., Westbury, NY). The sensitivity and
specificity of this assay has been shown to be 98.7% and
100%, respectively.76 Scra were diluted 1:100 and analyzed
according to the instructions of the manufacturer.
The study was approved by the Ethical Review Board of
the Medical Faculty, Uppsala University, and all case and
control patients gave informed consent to interviews.
Statistical Methods
'!-ests of significance in 2 X 2 tables were performed
by the Mantcl-Haens..cl x2 test. For odds ratios (ORs) ob-
tained from 2 X 2 tables, test-based confidence limits were
constructed using the Cornfield approximation" or an exact
computation when appropriate.ts The logistic regression
model was used in multivariate analyses of the relationship
hctwcen gastric cancer risk and possible risk factors. This
tnodcl assumes that the logarithm of the odds of having
gastric cancer is a linear function of explanatory variables
H. PYLOR! AND GASTRIC CANCER 1099
such as H. py/orl infection, vegetable consumption, etc. By
considering transformations of basic variables or catego-
rizcd variables, nonlinear relationships are also possible.
The model was estimated by the maximum likelihood
method. On the basis of the estimated (3 parameters and
their standard errors, ORs with confidence intervals (CI)
were computed. The OR is an estimation of relative risk.
Results
There were 112 case and 103 control patients,
of whom 71 (63g'o) and 68 (66%), respectively, were
men, The mean age of the case and the control patients
was 67 years. The prevalence of H. pylori seropositivity-
was significantly higher (P = 0.002) in case patients
(90 of 112; 80%) than in controls (63 of 103; 61%),
giving an OR of 2.60 (95% Cl, 1.35-5.02) (Table 1).
A stratified analysis with respect to gender showed a
significantly elevated OR in men (OR, 4.27; 95% Cl,
1.75-10.62) but not in women (OR, 1.26; 95% Cl,
0.43-3.71) (Table 1). In a multivariate logistic regres-
sion analysis including gender, H. pylori status, and an
interaction term for gender and H. pylori status, the OR
associated with H. pylori scropositivity and male gender
was 4.27 (95% Cl, 1.87-9.74) and the interaction term
was 0.30 (95% Cl, 0.08-1.05), which means that the
sex difference was not quite statistically significant.
The age group <60 years had an OR of 9.33, decreas-
ing to 4.27 in the group aged 60-69 years and to 1.15
in the oldest age group (Table 1). A multivariate logis-
tic regression analysis including age in continuous
form, H. pylorl status, and an interaction term between
age and H. pylorr status ((age - 40) X H. pylori status]
gave an OR for H. pylori seropositivity (at the age of 40)
of 41.5 (95% Cl, 3.78-456), with an interaction term
of 0.91 (95t1U CI, 0.84-0.98), showing a significant in-
teraction between age and H. pylori status. This means
that from the age of 40, OR decreases by 9% annually if
a linear effect of age is assumed (OR at 50, 60, and 70
years was 16.2, 6.3, and 2.5, respectively). The de-
creasing OR with age was attributable to an increasing
prevalence of H. pylori seropositivity with age in the
control patients and a decreasing prevalence of this
seropositivity with age among the case patients.
In a strati6ed analysis with respect to tumor loca-
tion within the stomach, only the OR for a noncardia
location was found to be significantly increased (3.06)
(Table 2). There were eight stump neoplasms (89%
with positive H. pylori serology), which were referred
to the noncardia group. If these stump neoplasms were
excluded from the noncarclia group, there was still a
significant association with positive H. pylorr serology
(OR, 2.96; 95% Cl, 1.42-6.23).

.
1100 HANSSON ET AL. GASTROENTEROLOGY Vol. 105, No. 4
.a
Table 1. Risk of Gastric Adenocarcinoma Associated with H. pylori infection: Stratified Analysis
With Respect to Age and Gender
Gastric cancer patients Control patients
Stratificption
group Mean No.
age (yr) seropositive (%) Mean
age (yr) No.
seropositive (%)
OR
95% Cl
:.
AII sub)ects
67 90/112
(80.4)
67
63/103 (61.2)
2.60
1.35-5.02
Men ` 66 61/71 (85.9) 64 40/68 (58.8) 4.27 1.75-10.62
Women 69 29/41 (70.7) 68 23/35 (65.7) 1.26 0.43-3.71
Age
<60 yr
- 21/23
(91.3)
-
9/17 (52.9)
9.33
1.38-100.73
60-69 yr - 27/33 (81.8) - 20/39 (51.3) 4.27 1.31-15.26
00 yr - 42/56 (75.0) - 34/47 (72.3) ' 1.15 0.44-3.02
Seventy-Bve of the cases (67%) had the intestinal
type of adenocarcinoma, 28 (259'0) had the diffuse type,
and 9 (8%) had the mixed type (Table 2). An increased
OR was noted for the intestinal and diffuse types, but
the increase only reached statistical significance for the
intestinal type. When the analysis was restricted to
noncardia cases, 81% of those with the intestinal type
(OR, 2.71; 95% CI, 1.19-6.29) and 85% of those with
t6e diffuse type (OR, 3.49; 95% Cl, 1.07-14.84) had
positive serology for N. py/ori.
Background data on dietary and socioeconomic
characteristics showed that the two groups were simi-
lar in terms of dietary habits, with the exception of a
higher consumption of citrus fruits (OR, 0.31; 95% Cl,
0.15-0.64) among the control patients and a higher
consumption of coffee (OR, 4.93; 95% C1, 2.66-9.17)
and hard liquor (OR, 2.53; 95% Cl, 0.99-6.61) among
the case patients. There was a higher percentage of
blue collar workers among the case patients (OR, 1.83;
9546 Cl, 1.00-3.34), whereas farmers and white collar
workers dominated slightly among the control pa-
tients.
A separate analysis aimed at revealing factors asso-
ciated with; the risk of acquiring H. py/ori infection was
performed within the control group. The mean age of
the seropositive and seronegative subjects was 69 and
65 years, respectively. H. pylorr infection tended to be
more prevalent among blue collar workers (OR, 1.92;
95% Cl, 0.80-4.66) than nonblue collar workers. Al-
though statistical significance was not reached, sero-
positive subjects were more likely to have a lower con-
sumption of vegetables (OR, 0.48; 95% CI, 0.19-1.17),
citrus fruits (OR, 0.49; 95% CI, 0.20-1.21), beer (OR,
0.51; 95% Cl, 0.14-1.86), wine (OR, 0.41; 95% Cl,
0.03-3.80), and liquor (OR, 0.19; 95% Cl, 0.02-1.15).
Seropositive subjects tended to have a higher con-
sumption of coffee (OR, 1.72; 95% CI, 0.66-4.58) and
more had a history of cigarette smoking (OR, 1.53;
95% Cl, 0.64-3.68), peptic ulcers (OR, 3.13; 95% CT,
0.89-13.85), use of H2-receptor antagonists (because
none of the control patients who had used H2-receptor
antagonists was seronegative, the OR could not be cal-
culated), and previous gastric resection (OR, 2.74; 95%
CI, 0.26-138.18). The numbers of subjects in the de-
scribed groups, however, were small.
Multivariate logistic regression analysis was used to
examine the risk of gastric cancer associated with H.
pylori seropositivity while taking into account possible
confounding factors. OR for seropositivity remained
virtually unchanged and was signi6cantly,inereased in
Table 2. Risk of Gastric Adenocarcinoma Associated With H. pylor! Infection: Stratified Analysis
With Respect to Tumor
Location and Histological Type
Patient group Mean age (yr) No. seropositive (%) OR' 95% Cl
All with gastric adenocarcinoma 67 90/112 (80.4) 2.60 1.35-5.02
Site of cancer°
Noncardia
68
77/93
(82.8)
3.06
1.49-6.31
Cardia 61 13/19 (68.4) 1.38 0.44-4.77
Histological type°
Intestinal
69
60/75
(80.0)
2.54
1.21-5.38
Diffuse 63 22/28 (78.6) 2.33 0.82-7.60
Mixed 68 8/9 (88.9) 5.08 0.63-230.92
'Reiative to control subjects.
°The whole control group was used as reference category in these stratified analyses.

October 1993
the model shown in Table 3. The model includes fac-
tors suggested to be associated with gastric cancer in
this or previous studies.
Discussion
The main finding in this study was the signifi-
cantly increased prevalence of H. pylori scropositivity
among patients with noncardia gastric cancer com-
pared with control patients. This difl'erence could not
be explained by dietary or socioeconomic factors. Our
finding of an overall OR of 2.60 is quite consistent
with two earlier case control studies with ORs of 2.675
and 2.21 6 An association between H. pylori infection
and gastric cancer has also been found in prospective
studies, two Americana.9 and one British; with ORs
ranging from 2.77 to 6.0. In one of these studies,° the
risk increase was confined largely to women (OR,
18.0), in contradiction to the moderately and statisti-
cally nonsignificant risk increase in women (OR, 1.26)
found in our study. However, the high OR in women
in the American studya could at least partly be ex-
plained by the fact that only 39.4% of the women con-
trol patients were infected, compared with 69.7% of
the men. In our study, the percentage of control pa-
tients infected was similar in men and women. This is
in line with the finding in a number of studies in both
developed and developing countries that the age-spe-
ciFic prevalence of infection was the same in both
genders.19-20
In the analysis with stratification by age, OR was
significantly increased in only the two younger age
groups. The reason for the absence of an excess risk
arnong the oldest cases was twofold. Firstly, the preva-
lence of H. pylori seropositivity increased with age in
the control patients. As the great majority of the popu-
lation will ultimately become infected, any differences
in infection rates'will tend to disappear in the oldest
Table 3. OR of Gastric Cancer and 95% Cl in a Multiple
Logistic Regression Model
OR Cl
H. pylorl seropositlvity 2.73 1.29-5.79
White collar worker' 0.87 0.38-2.00
Farmer 0.24 0.07-0.76
Access to refrigerator 20 yrs ago 0.26 0.05-1.25
High vegetable consumption 20 yrs ago 1.65 0.80-3.4 t
High citrus fruit consumption 20 yrs ago 0.22 0.09-0.54
Coffee consumption 1-3 cups/day° 2.12 0.59-7.58
Coffee consumption >3 cups/day' 10.50 2.92-37.70
High liquor, consumption 4.45 1.42-13.96
History of cigarette smoking 1.86 0.90-3.38
'Relerence category, blue collar worker.
°Reference category, coffee consumption < t cup/day.
H. PYLORI AND GASTRIC CANCER 1101
age groups when the rates among the control patients
catch up with those in the case patients. Secondly, the
percentage of infected cancer case patients decreased
in the oldest age groups. This was not unexpected, as
the unfavorable conditions for H. pylod survival asso-
ciated with the.precancerous atrophic gastritist21 may
cause the organism to disappear in some cases. Our
finding is in accordance with previous results of case
control and cohort studies.69 Thus, it seems as if early
acquisition of the infection increases the risk; this is
quite reasonable considering the probably long induc-
tion time for gastric cancer via gastritis, atrophy, and
metaplasia.
In patients with carcinoma located at the gastric
cardia, we found no significant association with H.
pylori infection in accordance with previous epidemio-
logicals," and clinical22 studies. There are several epi-
demiological features that distinguish cancer of the
gastric cardia from more distal gastric cancer,2s and the
difference in the association of these two cancer sites
with H. pylorr infection may be another indication of
different etiologies.
It has been hypothesized (mainly on the basis of the
pattern of occurrence) that the pathogenesis of the in-
testinal type of gastric carcinoma may be linked to
environmental factors, whereas the diffuse type may
have other causes, possibly genctic. As chronic atro-
phic gastritis (type B) has mainly been linked to the
intestinal type of gastric carcinoma,2'.2s H. pylorr infec-
tion would be expected to show the same relationship.
However, we found that H. pylod infection was asso-
ciated with an increased risk of both the intestinal and
the diffuse types of gastric carcinoma. The same obser-
vation was made in other seroepidemiological stud-
ies s.a.s,9 In one22 of two22~16 studies based on histologi-
cal diagnosis of H. pylori infection, a significantly
higher prevalence of this infection was noted among
patients with the intestinal type compared with the
diffuse type of gastric carcinoma. Nevertheless, most
data seem to indicate that there is no important differ-
ence between the two histological types ofgastric carci-
noma as far as their association with H. pylod is con-
cerned.
Could the increased prevalence of H. pylod among
the case patients be caused by increased susceptibility
of the cancerous stomach to become infected? Because
the blood samples were taken after the cancer diagno-
sis, this question would seem justified. Our finding
that OR was highest in the youngest age group and the
fact that precancerous conditions, such as atrophy and
intestinal mctaplasia, are unfavorable for H. pylod col-
onization contradict this possibility. Another potential

1102 HANSSON ET AL.
source of error in this study may be that the control
group of hospitalized patients was not representative
of the study base. Our finding of a 61% prevalence of
H. pylori'seropositivity, howevcr, corresponds well
with rcports from other Western populations with the
same age distribution.12,2'als Another source of
concern is the fact that the case patients underwent
face-to-face interviews about their diet and other
hacfcground charactcristics as part of a large epidemio-
logical project on gastric cancer, whereas the control
patients, for cost-saving reasons, were given self-ad-
ministered questionnaires. This may potentially result
in differential misclassification. Hence, the varying
distributions of the variables between the case and
control patients, indicating some of them as possible
risk factors of gastric carcinoma, should be interpreted
with caution.
Both H. pylori infection'272° and gastric cancertt are
more prevalent in populations with poor socioeco-
nomic conditions; this may be a potential confounding
factor. However, in our study, the OR associated with
H. pylori infection remained significantly increased in
multivariate logistic regression models, making con-
founding by these variables less likely. Hence, H. pylori
seems to be an independent risk indicator of gastric
carcinoma.
f"l'here arc several possible mechanisms by which H.
pylorr infection may be involved in gastric carcinogene-
sis.1-1. pylori adversely affects the chemical and physical
properties of the mucus laycr,"' which may make the
mucosa susceptible to carcinogenic factors. Acute in-
fection by 1-1. pylori has been reported to result in pro-
longed inhibition of the naturally occurring gastric se-
cretion of ascorbic acicl.'t This secretion also seems to
be decreased in chronic gastritis, thereby permitting a
greater degree of intragastric formation of N-nitroso
compounds. Moreover, H. pylori seems to act as a pro-
moter in the progression from normal to metaplastic
epithelium, possibly by inclucing a hyperprolifcrative
state in the inflamed gastric mucosa.° Finally, the
chronic inAammation per se may expose the mucosal
cells to the oxidativc stress of free radicals generated
from the inf-ammatory cells12
There are several issues to be resolved, however,
before the association between H. pylorr and gastric
cancer can be accepted as causal. There are several
populations, e.g., in ChinaZ and Africa,'9 where H. py-
lori infection is prevalent at young ages but gastric
cancer is uncommon. There is a lack of specificity, as
H. pylori infection seems to be a risk indicator of both
intestinal and diffuse types of adenocarcinoma,3'9 as
well as gastric lymphomas.s" If, as several studies sug-
GASTROENTEROLOGY Vol. 105, No. 4
gest,'7," H. pylori is an important causal factor in duo-
denal ulccr, the negative association between duodenal
ulcer and later development of gastric cancer's is per-
plexing. Thus, the role of H. pylori in the complex mul-
tifactorial carcinogenesis of gastric cancer needs to be
explored further.
References
1. Dixon MF. Campylobacter pylorl and chronic gastritis. In: Rath-
bone BJ, Heatley RV, eds. Campylobacter pylori and gastroduo-
denal disease. Oxford, England: Blackwell Scientific, 1989; ! 06-
116.
2. Forman D, Sitas F. Newell DG, Stacey AR, Boreham J, Peto R,
Campbell TC, U J, Chen J. Geographic association of Hetico-
bacter pylort antibody prevalence and gastric cancer mortality in
rural China. Int J Cancer 1990;46:608-611.
3. Burstein M, Mouge E, Le6n-Barfa R. Lozano R, Berendson R,
Gilman RH, Legua H, Rodriguez C. Low peptic ulcer and high
gastric cancer prevalence In a developing country with a high
prevalence of infection by Nellcobacter pylori. J Clin Gastroen-
terol 1991;13:154-156.
4. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D. Taylor N,
Mackinley D, de Lima E, Portilla H, Zarama G. Nellcobacter pylori
and gastric carcinoma. Serum antibody prevalence in poputa-
tions with contrasting cancer risks. Cancer 1990;66:2569-
2574.
5. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA,
Perez-Perez G1, Blaser MJ. Gastric carcinoma and Nelicobacter
pylorf infection.l Nati Cancer Inst 1991;83:1734-1739.
6. Sipponen P, Kosunen TU, Valle T, Riihela M, Seppala K. Netico-
bacter pyforf infection and chronic gastritis in gastric cancer. J
Clin Pathol 1992;45:319-323.
7. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald
N, Sitas F. Association between Infection with Helicobacter py-
forl and risk of gastric cancer: evidence from a prospective inves-
tigation. BMJ 1991:302:1302-1305.
8. Parsonnet J. Friedman GD, Vandersteen DP, Chang Y, Vogelman
IN, Orentreich N, Sibley RK. Helfcobacter pylori infection and the
risk of gastric carcinoma. N Eng- J Med 1991:325:1127-1131.
9. Nomura A, Stemmermann GN, Chyou PH. Kato I, Perez-Perez GI,
Blaser M1. Helicobacter pytorl Infection and gastric carcinoma
among Japanese Americans In Hawaii. N Engl J Med
1991;325:1132-1136.
10. Boeing H. Epidemiological research In stomach cancer: progress
over the last ten years. J Cancer Res Clin Oncol 1991;117:133-
143.
11. Howson CP, Hlyama T, Wynder EL. The decline in gastric cancer:
epidemiology of an unplanned triumph. Epidemtol Rev 1986;
8:1-27.
12. Taylor ON, Blaser MJ. Epidemiology of Hellcobacter pylorl infec-
tions. Epidemlol Rev 199 1; 13:42-59.
13. Hansson LE, Nyran 0, Bergstrtlm R, Wolk A, Lindgren A, Baron J.
Adaml HO. Diet and risk of gastric cancer. A population-based
case-control study In Sweden. Int J Cancer (in press).
14. Statistics Sweden. Swedish socioeconomic classification. Re-
ports on statistical coordination. Stockholm: Statistics Sweden.
1982:4.
15. LaurAn P. The two histological main types of gastric carcinoma.
diffuse and so-called intestinal-type carcinoma: an attempt at a
histociinicai ctas ircati APMtS 1965 6431 49
s i n
.
16. Evans DJ Jr, Evans DG, Graham DY, Klein PD. A sensitive and
specific serologic test for detection of Campylobacfer pylor( in-
fection. Gastroenterology 1989;96:1004-1008.
17. Fleiss iL. Statistical methods for rates and proportions. New
York: WIley, 1981.
QD --
GO
Cr
Pz

...
I
Octotier 1993
18. Mehta CR, Patel,NR, Gray R. Computing an exact confidence
Intervat for the common odds ratio In several 2 X 2 contingency
tables.l Am Statistical Assoc 1985;80:969-973.
19. MEgraud F, Brassens-Rabb6 M-P, Denis F. Belbouri A, Hoa DQ.
Seroepidemlology of Campylobacter pylori infection in various
populations.l Clin Microblol 1989;27:1870-1873.
20. Graham DY, Maiaty HM, Evans DG, Evans DG Jr, Klein PD, Adam
E. Epidemiology of Welloobacter pylorl in an asymptomatic popu-
lation In the United States. Effect of age. race, and socioeco-
nomic status. Gastroenterology 1991;100:1495-1501.
21. Siuraia M, Sipponen P. Kekki M. Campylobacter pylorl in a sam-
ple of Finnish population; relations to morphology and functions
of the gastric mucosa. Gut 1988;29:909-915.
22. Parsonnet J, Vandersteen D, Goates J. Sibley RK, Pritikin J.
Chang Y. Helicobacter pylori infection In intestinal and diffuse-
type gastric adenocarcinomas. J Nati Cancer inst 1991;83:640-
643.
23. Hansson L-E. SparE:n P. Nyr6n 0. Increasing Incidence of carci-
noma of the gastric cardia in Sweden 1970-1985. Br J Surgery
1993;80:374-377.
24. Correa P. Cuello C, Duque E. Burbano I.C. Garcia FT. Bolaftos 0.
Gastric cancer In Colombia. Ill. Natural history of precursor le-
sions. J Nati Cancer Inst 1976;47:1021-1026.
25. Correa P, Haenszel W, Cuello C. Zavala D, Fontham E, Zarama G.
Gastrtc precancerous process in a high risk population: cohort
foliowup. Cancer Res 1990;50:4737-4740.
26. Loffeld RJLF, Willems i, Flendrig JA, Arends JW. Helicobacter py-
torJ and gastric carcinoma. Histopathology 1990;17:537-541.
27. Sitas F, Forman D. Yarnell JWG, Btur ML. Elwood PC, Pedley S.
Marks KJ. Hellcobacter pylori Infection rates in reiation to age
and social class in a population of Welsh men. Gut 1991;32:25-
28.
28. Kosunen TU, Ht1t1k J. Rauleiin HJ, Myliyla G. Age-dependent in-
crease of Campylobacter pylorl antibodies In blood donors.
Scand J Gastroenterol 1989;24:110-114.
29. The Gastrointestinal Physiology Working Group. Hellcobacter py-
H. PYLORI AND GASTRIC CANCER 1103
lorl and gastritis in Peruvian patients: relationship to socioeco-
nomic level, age, and sex. Am J Gastroenterol 1990;85:819-
823.
30. Sarosick J, Peura DA, Guerrant PL, Marshall B1, Laszewicz W,
Gabryelewicz A, McCallum RW. Mucolytic effects of Helicobacter
pylorf. Scand J Gastroenterol 199 1; 187:87:47-55.
31. Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, TaylorJD, Rath-
bone BJ, Heatley RV, Axon ATR. Acute Hellcobacter pylorJ infec-
tions clinical features, local and systemic immune response, gas-
tric mucosal histplogy, and gastric juice ascorbic acid
concentrations. Gut l 991;32:14 ! 5-1418.
32. Ames BN, Motchnik P, Profet M. Shigenaga MK, Hagen TM. An-
tioxidant prevention of birth defects and cancer. Presented at the
international conference on male-mediated developmental toxic-
ity; September 16-19, 1992; Pittsburgh, Pennsylvania. New
York: Plenum (in press)
33. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Hell-
cobacter pylori-associated gastritis and primary B-cell gastric
lymphoma. Lancet i991;338:1175-1176.
34. Blaser MJ, Perez-Perez Cl, Lindenbaum J, Schneidman D, Van
Deventer' G, Marin-Sorensen M, Weinstein WM. Association of
infection due to Helicobacter pylorl with specific upper gastroin-
testinal pathology. Rev Infect Dis 1991;8(suppi 13):S704-
S708.
35. Lee S, lida M, Yao T. Schindo S, Nose K. Akazawa K. Okabe H,
Fujishima M. Risk of gastric cancer in patients with non-surgically
treated peptic ulcer. Scand J Gastroenterol 1990;25:1223-
i226.
Received March 3, 1993. Accepted June 3, 1993.
Address requests for reprints to: Lars-Erik Hansson, M.D., Depart-
ment of Surgery, University Hospital, S-751 85 llppsala, Sweden.
Supported by grants from the Swedish Society of Medicine, Pro-'
fessor Nanna Svartz Foundatlon, and Tore Nllsson Foundation.
The authors thank Ulla Zettersten for excellent technicai assis-
tance.
